KariAnnYacisinMD

Infectious Disease • Dallas, TX

Physician

Join to view full profile

Are you Dr. Yacisin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
5201 Harry Hines Blvd
House Staff & Gme
Dallas, TX 75235
Phone+1 214-590-8058

Summary

Dr. Kari Yacisin, MD is an infectious disease specialist in Dallas, Texas. She is currently licensed to practice medicine in New York, Pennsylvania, and New Hampshire.

Education & Training

University of New Mexico School of MedicineFellowship, Infectious Disease, 2011 - 2013
University of Utah HealthResidency, Internal Medicine, 2009 - 2011
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 2008 - 2009
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2008

Certifications & Licensure

NH State Medical License 2015 - Present
NM State Medical License 2011 - 2027
NY State Medical License 2019 - 2024
PA State Medical License 2019 - 2022
UT State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

2 citations
Attributable Cost of Adult Respiratory Syncytial Virus Illness Beyond the Acute Phase.
Ahuva Averin, Mark Atwood, Reiko Sato, Kari Yacisin, Elizabeth Begier
Open Forum Infectious Diseases. 2024-03-01
4 citations
Rates of Lower Respiratory Tract Illness in US Adults by Age and Comorbidity Profile.
Derek Weycker, Ahuva Averin, Linnea Houde, Kevin Ottino, Kimberly Shea
Infectious Diseases and Therapy. 2024-01-01
2 citations
Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumoco...
David Fitz-Patrick, Mariano Young, Kari Yacisin, Kathleen McElwee, Todd Belanger
Vaccine. 2023-06-23

Press Mentions

Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022October 18th, 2022